Who owns NeuroMetrix?
Key information on NeuroMetrix (Ticker: NURO)
- CUSIP: 641255104
Who owns NeuroMetrix?
Is NURO a good stock to own? Find out who bought NeuroMetrix, who sold NeuroMetrix (NURO) stock, and who holds a large position in NeuroMetrix.
- NEA Management Company owns 57273 shares worth $140891
Who sold NeuroMetrix?
- Cacti Asset Management sold on Sept. 30, 2011
- T. Rowe Price Associates sold on Aug. 12, 2011
- GRT Capital Partners sold on June 30, 2011
- GMT Capital sold on June 30, 2011
- D. E. Shaw & Co sold on June 30, 2011
- CalPERS sold on June 30, 2011
- Vanguard sold on June 30, 2011
- Johnson Investment Counsel sold on June 30, 2011
- Gabelli Securities sold on June 30, 2011
- Rima Management sold on June 30, 2011
- Wells Fargo & Company sold on March 31, 2011
- Knight Capital sold on Dec. 31, 2010
- Janney Montgomery Scott sold on Dec. 31, 2010
- UBS AG sold on Dec. 31, 2010
- Public Employees' Retirement Association of Colorado sold on Sept. 30, 2010
- Manulife Asset Management sold on Dec. 31, 2007
- Manulife Asset Management sold on Dec. 31, 2007
- Zebra Capital Management sold on June 30, 2007
- Tradeworx sold on Dec. 31, 2006
- Navellier & Associates sold on June 30, 2006
Funds that own NURO also own:
- InterMune (ITMN)
- ArQule (ARQL)
- Exelixis (EXEL)
- Nektar Therapeutics (NKTR)
- Rigel Pharmaceuticals (RIGL)
- Lexicon Pharmaceuticals (LXRX)
- Targacept (TRGT)
- NeuroMetrix (NURO)
- Solta Medical (SLTM)
- Sunesis Pharmaceuticals (SNSS)
- Zhone Technologies (ZHNE)
- Amicus Therapeutics (FOLD)
- Cadence Pharmaceuticals (CADX)
- Transcept Pharmaceuticals (TSPT)
- Alimera Sciences (ALIM)
- Glu Mobile (GLUU)